According to MRFR analysis, the global Central Nervous System Biomarkers market share is expected to register a CAGR of~13.0%from 2021 to 2027and hold a value of over ~USD 7,500 million by 2027. The global CNS biomarkers market is driven by several factors, such astechnological advancements, an increase in the use of biomarkers inthe diagnosis of neurodegenerative diseases, increasing...